Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Augmenting Clinical Workflow With a Structured Chatbot for Patient History Collection and Diagnostic Support (CHAT-HX)

maanantai 5. lokakuuta 2026 päivittänyt: Sonu Subudhi, Massachusetts General Hospital

Prospective Observational Evaluation of a Structured, Agentic AI Chatbot for Pre-Visit Patient History Collection and Diagnostic Support in Outpatient Clinical Workflows

Doctors spend much of each visit collecting the patient's medical history, and incomplete histories can delay diagnosis. This study tests an AI chatbot that interviews patients before their appointment and produces a structured summary of their history for the doctor. Adult patients at the first study site, a university gynecology outpatient clinic in Germany, answer the chatbot's questions on a tablet before the doctor visit. The doctor then takes the history and examines the patient as usual, without seeing the chatbot's output. Only after the doctor has finished planning care does the doctor review the chatbot's summary and rate its usefulness and accuracy. The chatbot does not change patient care. Patients also rate the ease of use and acceptability of the chatbot. The investigators will report how useful doctors find the summaries, how complete and correct the summaries are, and how patients experience the tool.

Tutkimuksen yleiskatsaus

Yksityiskohtainen kuvaus

This is a prospective, observational study of an AI-based, structured history-taking tool used before a clinical visit. The tool uses large language models and follows a fixed interview plan with defined topic blocks, such as chief complaint, current history, past conditions, medications, allergies, specialty-specific history, and social and family history. It produces a structured history summary, a list of possible diagnoses, and suggested workup steps. In earlier benchmarking on more than 670 simulated and clinical cases, the system captured most clinically relevant history items and flagged clinically important warning signs.

The study is designed so that the tool does not influence care. Participants give written informed consent, then complete the AI interview on a study tablet using a pseudonymous study ID. Participants enter no name, birth date, or address. Participants then complete a short questionnaire on usability and acceptance. The treating physician takes a full history, examines the patient, and documents a plan without access to the AI output. Only afterward does the physician receive the AI output and complete a structured evaluation of its completeness, correctness, plausibility, and usefulness. No follow-up contact occurs after the visit.

The study is not randomized and has no control arm. The physician's independently obtained history serves as the reference standard. The first site is the Department of Gynecology at Leipzig University Hospital, with about 100 patients and 8 to 15 physicians. Analysis is descriptive, with subgroup comparisons by reason for visit. Additional sites may be added later. The study is a collaboration between Leipzig University Hospital and Massachusetts General Hospital and Harvard Medical School.

Opintotyyppi

Havainnollistava

Ilmoittautuminen (Arvioitu)

100

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskeluyhteys

Opiskelupaikat

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

18 vuotta ja vanhemmat (Aikuinen, Vanhempi Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Nainen

Näytteenottomenetelmä

Ei-todennäköisyysnäyte

Tutkimusväestö

Adult women presenting for the first time, or with a new complaint, to the general gynecology outpatient clinic, the gynecology emergency clinic, or as referrals to the gynecology outpatient clinic at the first study site (Leipzig University Hospital, Germany). Patients are recruited consecutively in the clinic waiting area by trained study staff. Additional sites may be added later.

Kuvaus

Inclusion Criteria:

Women 18 years or older

First presentation or new complaint at the gynecology outpatient clinic (self-presentation, emergency, or referral)

Sufficient German language skills to complete a structured patient interview independently

Able to complete study participation without external support

Written informed consent

Exclusion Criteria:

Acute emergency requiring immediate treatment (for example, impaired consciousness, hemodynamic instability, or acute bleeding requiring immediate care)

Lack of legal or decisional capacity to consent

Insufficient language skills

Severe cognitive, visual, or motor impairment preventing tablet use

Previous participation in this study

Refusal or withdrawal of consent

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Havaintomallit: COHORT
  • Aikanäkymät: PROSPECTIVE

Kohortit ja interventiot

Ryhmä/Kohortti
Interventio / Hoito
Adult Clinic Patients

Adult patients with a first presentation or new complaint at the participating outpatient clinic who consent to complete the AI-based pre-visit history interview and questionnaire. Their physician completes routine care blinded to the AI output, then evaluates the AI-generated summary.

A large language model-based agentic chatbot that conducts a structured, pre-visit history interview on a study tablet and generates a history summary, differential diagnosis list, and workup suggestions. The output is released to the treating physician only after the physician has completed an independent history, examination, and care plan, and does not influence patient care.

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Proportion of AI history summaries rated useful by the evaluating physician
Aikaikkuna: Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)

After completing routine care, the treating physician rates the usefulness of the AI-generated history summary on a 5-point Likert scale (1 = not useful at all, 5 = very useful). The outcome is the proportion of summaries rated 4 or higher, reported with a 95% Wilson confidence interval.

Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Completeness of the AI-generated history
Aikaikkuna: Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)

Percentage of items from a standardized history grid that the AI captured correctly, reported overall and by history domain.

Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
Correctness of the AI-generated history
Aikaikkuna: Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)

Proportion of factually incorrect or missing clinically relevant items in the AI history, per physician review.

Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
Plausibility of AI differential diagnoses
Aikaikkuna: Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)

Physician rating of plausibility on a 1-5 Likert scale, and concordance of the AI differential with the physician's working diagnosis.

Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
Plausibility of AI workup recommendations
Aikaikkuna: Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)

Physician rating of the AI's suggested diagnostic workup on a 1-5 Likert scale.

Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
Identification of clinically relevant red flags
Aikaikkuna: Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)

Proportion of clinically relevant red flags correctly recognized by the AI versus not recognized, per physician review.

Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
Patient usability (System Usability Scale)
Aikaikkuna: Same day as the enrollment visit, immediately after the AI interview or after the physician consultation (up to approximately 1 day)

Patient-completed System Usability Scale, score 0-100, higher scores indicating better usability.

Same day as the enrollment visit, immediately after the AI interview or after the physician consultation (up to approximately 1 day)
Patient acceptance and willingness to use the tool again
Aikaikkuna: Same day as the enrollment visit, immediately after the AI interview or after the physician consultation (up to approximately 1 day)

Patient-reported acceptance, comprehensibility, empathy, comfort, trust, and willingness to use again, each on a 1-5 Likert scale.

Same day as the enrollment visit, immediately after the AI interview or after the physician consultation (up to approximately 1 day)
Duration of the AI interaction
Aikaikkuna: During the AI interview at the enrollment visit (approximately 15 minutes)

Time in minutes for the patient to complete the AI interview, recorded automatically by the system.

During the AI interview at the enrollment visit (approximately 15 minutes)
Physician-estimated time savings
Aikaikkuna: Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)

Physician's estimate, in minutes, of the time the AI history would save in clinical workflow.

Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Julkaisuja ja hyödyllisiä linkkejä

Tutkimusta koskevien tietojen syöttämisestä vastaava henkilö toimittaa nämä julkaisut vapaaehtoisesti. Nämä voivat koskea mitä tahansa tutkimukseen liittyvää.

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Arvioitu)

Perjantai 2. lokakuuta 2026

Ensisijainen valmistuminen (Arvioitu)

Sunnuntai 28. helmikuuta 2027

Opintojen valmistuminen (Arvioitu)

Perjantai 1. lokakuuta 2027

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Keskiviikko 30. syyskuuta 2026

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Keskiviikko 30. syyskuuta 2026

Ensimmäinen Lähetetty (Todellinen)

Tiistai 6. lokakuuta 2026

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Keskiviikko 7. lokakuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Maanantai 5. lokakuuta 2026

Viimeksi vahvistettu

Tiistai 1. syyskuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Muut tutkimustunnusnumerot

  • 2026P001764
  • 201/26-ek (Muu tunniste: Ethics Committee, Medical Faculty, Leipzig University)

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

EI

IPD-suunnitelman kuvaus

Individual participant data will not be shared with outside researchers. Participants consented under a German ethics-approved form that permits only fully anonymized, aggregated data to be shared with collaborating study partners for analysis and publication. Data are pseudonymized, are classified as health data under GDPR, and remain on servers of the clinical site. De-identified aggregate results will be reported in publications.

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa